By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kiadis Pharma 

Zernikepark 6-8

Groningen    9747 AN  The Netherlands
Phone: 31-0-50-547-42-70 Fax: 31-0-50-547-42-71



Company News
One Year Data From Kiadis Pharma's Ongoing Phase II Trial With ATIR101 Will Be Presented At American Society of Hematology 2016 Annual Meeting 11/3/2016 8:52:15 AM
Kiadis Pharma Announces Financial Results For The Six Months Ended June 30, 2016 8/26/2016 8:36:29 AM
Kiadis Pharma Notice Of Results For The Six Months Ended 30 June 2016 8/19/2016 8:48:58 AM
Kiadis Pharma And The Leukemia & Lymphoma Society Strengthen Partnership Around The Development Of ATIR101 In ALL And AML Patients 7/11/2016 9:05:12 AM
Kiadis Pharma’s Orphan Drug Designation For ATIR101 Further Expanded To Include Treatment In A Hematopoietic Stem Cell Transplantation 6/30/2016 11:59:35 AM
Kiadis Pharma Announces Result Of Annual General Meeting 6/28/2016 2:22:32 PM
Kiadis Pharma Appoints PCT As Its Contract Manufacturing Organization In The United States 6/21/2016 9:33:56 AM
Kiadis Pharma Announces Its Decision To File For Marketing Authorization With European Medicines Agency For ATIR101 In Blood Cancers 6/2/2016 9:14:15 AM
Kiadis Pharma Presents Multiple Sets Of Data At The International Society For Cellular Therapy (ISCT) 2016 Annual Meeting 5/18/2016 9:06:04 AM
Kiadis Pharma Announces Annual Results For The Year Ended 31 December 2015 4/15/2016 8:41:10 AM